Clinical utility of hypo- and hyperpigmentation of skin in diffuse cutaneous systemic sclerosis.

about

Clinical utility of hypo- and hyperpigmentation of skin in diffuse cutaneous systemic sclerosis.

Item

http://www.wikidata.org/entity/Q47839424

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Clinical utility of hypo- and ...... cutaneous systemic sclerosis.

@en

Clinical utility of hypo- and ...... cutaneous systemic sclerosis.

@nl

type

Item

label

Clinical utility of hypo- and ...... cutaneous systemic sclerosis.

@en

Clinical utility of hypo- and ...... cutaneous systemic sclerosis.

@nl

prefLabel

Clinical utility of hypo- and ...... cutaneous systemic sclerosis.

@en

Clinical utility of hypo- and ...... cutaneous systemic sclerosis.

@nl

P1476

Clinical utility of hypo- and ...... cutaneous systemic sclerosis.

@en

P2093

Cecil Hor

http://www.w3.org/2001/XMLSchema#string

Christopher Frampton

http://www.w3.org/2001/XMLSchema#string

Douglas H N White

http://www.w3.org/2001/XMLSchema#string

Kamal K Solanki

http://www.w3.org/2001/XMLSchema#string

Winston S J Chang

http://www.w3.org/2001/XMLSchema#string

P2860

Rituximab in diffuse cutaneous systemic sclerosis: should we be using it today?

Outcome measures in systemic sclerosis: an update on instruments and current research.

Skin involvement in systemic sclerosis.

Systemic sclerosis in 3 US ethnic groups: a comparison of clinical, sociodemographic, serologic, and immunogenetic determinants.

Preliminary analysis of the very early diagnosis of systemic sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis.

A cross-sectional study of autoantibody profiles in the Waikato systemic sclerosis cohort, New Zealand.

Salt-and-pepper Appearance: A Cutaneous Clue for the Diagnosis of Systemic Sclerosis.

Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database.

Improvement in skin thickening in systemic sclerosis associated with improved survival.

Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trial.

P304

767-773

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/1756-185X.13049

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-03-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28261995

http://www.w3.org/2001/XMLSchema#string

P921

hyperpigmentation